Brensocatib Impurity 47 | CAS 2165880-32-8 - Request Quote
Brensocatib Impurity 47
| SZ CAT No: | SZ-B145054 |
| CAS No | 2165880-32-8 |
| Mol.F. | C6H11NO3 |
| Mol.Wt. |
145.2 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Brensocatib Impurity 47 is chemically (S)-1,4-oxazepane-2-carboxylic acid. Brensocatib Impurity 47 is supplied with detailed characterization data compliant with regulatory guideline. Brensocatib Impurity 47 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brensocatib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2165880-32-8
Purchase 2165880-32-8
Order 2165880-32-8
Enquire 2165880-32-8
price of 2165880-32-8
2165880-32-8 Supplier
2165880-32-8 Manufacturer
2165880-32-8 Exporter
buy high quality Brensocatib Impurity 47
Purchase Brensocatib Impurity 47
Brensocatib Impurity 47 suppliers
Brensocatib Impurity 47 manufacturers
Brensocatib Impurity 47 price
Order Brensocatib Impurity 47
Enquire Brensocatib Impurity 47
Brensocatib Impurity 47 cost
Brensocatib Impurity 47 Supplier
Brensocatib Impurity 47 Distributor
Brensocatib Impurity 47 for Method Validation
Brensocatib Reference Standard
Brensocatib Impurity 47 for ANDA Filing
Brensocatib Impurity 47 for Forced Degradation Studies
Brensocatib Impurity 47 Identification Standards
Brensocatib Impurity 47 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.